781 related articles for article (PubMed ID: 32306929)
1. Lamotrigine, quetiapine and aripiprazole-induced neuroleptic malignant syndrome in a patient with renal failure caused by lithium: a case report.
Szota AM; Radajewska I; Grudzka P; Araszkiewicz A
BMC Psychiatry; 2020 Apr; 20(1):179. PubMed ID: 32306929
[TBL] [Abstract][Full Text] [Related]
2. Atypical Neuroleptic Malignant Syndrome: Case Reports and Diagnostic Challenges.
Szota AM; Radajewska I; Araszkiewicz AS
J Psychoactive Drugs; 2022; 54(3):284-293. PubMed ID: 34340640
[TBL] [Abstract][Full Text] [Related]
3. A Case of Neuroleptic Malignant Syndrome in the Context of Lithium Toxicity and Aripiprazole Use.
Schultz AR; Singh S; Linek-Rajapaksha CE; Goode HR; Fusick AJ
Clin Neuropharmacol; 2024 Jan-Feb 01; 47(1):22-25. PubMed ID: 37874611
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Woodward TC; Tafesse E; Quon P; Lazarus A
Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
[TBL] [Abstract][Full Text] [Related]
5. Subcortical Structure Disruption in Diffusion Tensor Tractography of the Patient With the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity Combined With Neuroleptic Malignant Syndrome: A Case Report.
Rhee SY; Kim HS
Clin Neuropharmacol; 2021 Mar-Apr 01; 44(2):62-67. PubMed ID: 33560007
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Croarkin PE; Emslie GJ; Mayes TL
J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
[TBL] [Abstract][Full Text] [Related]
7. Fatal Neuroleptic Malignant Syndrome Associated With Quetiapine.
Schattner A; Kitroser E; Cohen JD
Am J Ther; 2016; 23(5):e1209-10. PubMed ID: 26132604
[TBL] [Abstract][Full Text] [Related]
8. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
Maher AR; Theodore G
J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
[TBL] [Abstract][Full Text] [Related]
9. A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.
Chiou YJ; Lee Y; Lin CC; Huang TL
Medicine (Baltimore); 2015 Oct; 94(43):e1752. PubMed ID: 26512569
[TBL] [Abstract][Full Text] [Related]
10. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Jing Y; Kim E; You M; Pikalov A; Tran QV
J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
[TBL] [Abstract][Full Text] [Related]
11. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
12. Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
Hooshmand F; Miller S; Dore J; Wang PW; Hill SJ; Portillo N; Ketter TA
J Affect Disord; 2014 Feb; 155():283-7. PubMed ID: 24314912
[TBL] [Abstract][Full Text] [Related]
13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic Malignant Syndrome Secondary to Quetiapine in Critical Care: A Case Report.
Nestor C; O'Brien D; Dwyer R
A A Pract; 2020 Sep; 14(11):e01318. PubMed ID: 32985851
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?
Tripathi P; Agrawal H; Goyal P; Kar SK
Ind Psychiatry J; 2013 Jul; 22(2):159-60. PubMed ID: 25013321
[TBL] [Abstract][Full Text] [Related]
16. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.
Patel MK; Brunetti L
Am J Health Syst Pharm; 2010 Aug; 67(15):1254-9. PubMed ID: 20651315
[TBL] [Abstract][Full Text] [Related]
19. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.
Trollor JN; Chen X; Sachdev PS
CNS Drugs; 2009; 23(6):477-92. PubMed ID: 19480467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
